
LakeShore Biopharma
(OTC) LSBCF
LakeShore Biopharma Financials at a Glance
Market Cap
$2.88M
Revenue (TTM)
CN¥577.33M
Net Income (TTM)
-CN¥433.70M
EPS (TTM)
$0.00
P/E Ratio
0.01
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Price
$0.10
Volume
20,000
Open
$0.10
Price
$0.10
Volume
20,000
Open
$0.10
Previous Close
$0.10
Daily Range
$0.10 - $0.10
52-Week Range
$0.03 - $1.48
Dividend
$0.00
Beta (Volatility)
0.54 (Low)
Price
$0.10
Volume
20,000
Open
$0.10
Previous Close
$0.10
Daily Range
$0.10 - $0.10
52-Week Range
$0.03 - $1.48
LSBCF News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout LakeShore Biopharma
Industry
Biotechnology
Sector
Health CareEmployees
573
CEO
Xu Wang
Website
www.lakeshorebio.comHeadquarters
Beijing, 102629, CN
LSBCF Financials
Key Financial Metrics (TTM)
Gross Margin
82%
Operating Margin
-14%
Net Income Margin
-16%
Return on Equity
0%
Return on Capital
-16%
Return on Assets
-7%
Earnings Yield
100.00%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$2.88M
Shares Outstanding
41.21M
Volume
20.00K
Avg. Volume
5.36K
Financials (TTM)
Gross Profit
CN¥507.19M
Operating Income
-CN¥86.29M
EBITDA
-CN¥48.54M
Operating Cash Flow
-CN¥120.98M
Capital Expenditure
-CN¥17.86M
Free Cash Flow
-CN¥138.84M
Cash & ST Invst.
CN¥28.08M
Total Debt
CN¥414.40M
LakeShore Biopharma Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥135.53M
+27.7%
Gross Profit
CN¥34.41M
-59.5%
Gross Margin
25.39%
N/A
Market Cap
$2.88M
N/A
Market Cap/Employee
$3.81K
N/A
Employees
758
N/A
Net Income
-CN¥181.41M
-63.3%
EBITDA
-CN¥82.62M
-48.4%
Quarterly Fundamentals
Net Cash
-CN¥386.32M
-31.3%
Accounts Receivable
CN¥501.79M
+16.9%
Inventory
CN¥227.59M
+6.9%
Long Term Debt
CN¥23.50M
-93.6%
Short Term Debt
CN¥390.90M
+1200.5%
Return on Assets
-7.31%
N/A
Return on Invested Capital
-15.89%
N/A
Free Cash Flow
CN¥0.00
N/A
Operating Cash Flow
CN¥0.00
N/A